Bills · HR 2767
IN COMMITTEE· 119TH CONGRESS
House BillHR 2767Health
BRAIN Act
INTRO APR 9· LAST ACTION APR 9
READING
13MIN
COSPONSORS
65
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenBrain tumors represent a significant health challenge, with over a million Americans currently living with a brain tumor and new diagnoses occurring daily. Many types, particularly glioblastoma, have very poor survival rates, and pediatric brain tumors are a leading cause of cancer-related death in children. This bill aims to directly address these urgent issues by boosting critical research and making research materials more accessible.
If this bill becomes law, it could accelerate the discovery of new treatments and therapies by fostering collaboration and providing dedicated funding for cutting-edge research. It could also lead to improved diagnostics and care for survivors. Without this bill, research efforts might continue at a slower pace due to fragmented resources and less targeted funding, potentially delaying breakthroughs that could save lives and improve the quality of life for brain tumor patients.
KEY PROVISIONS
5AI-extractedPROVISION 01
Requires individuals and entities maintaining NIH-funded brain tumor biospecimen collections to report information about these collections to the NIH Director, which may then be made publicly accessible on a searchable website.
This makes valuable research materials more discoverable and accessible to brain cancer researchers, potentially speeding up scientific discoveries.
PROVISION 02
Establishes a 'Glioblastoma Therapeutics Network' research program at the National Institutes of Health (NIH), providing competitive awards to institutions collaborating on glioblastoma treatment development from early lab studies through initial human trials.
This focuses dedicated research efforts and funding on glioblastoma, a highly aggressive and often fatal brain tumor with very limited treatment options.
PROVISION 03
Authorizes NIH to make competitive awards to support multi-institutional team science approaches for developing and utilizing brain tumor related cellular immunotherapy, including CAR-T, for both adult and pediatric brain tumors.
This supports innovative, cutting-edge treatments like CAR-T, which have shown promise in other cancers, and encourages collaborative research for brain tumors.
PROVISION 04
Calls for a national public awareness campaign regarding cancer clinical trials and biomarker testing (based on the title of Section 5).
Could increase patient participation in trials and utilization of personalized medicine approaches, though specific details are not provided.
PROVISION 05
Directs the creation of pilot programs to develop, study, or evaluate approaches for monitoring and caring for brain tumor survivors (based on the title of Section 6).
Could improve the long-term quality of life and health outcomes for individuals who have survived brain tumors, addressing post-treatment needs.
SPONSORSHIP
1 + 65
R· Pennsylvania
YRS IN OFFICE
9
BILLS LED
86
COSPONSOR BREAKDOWNBIPARTISAN · 34%
DEM 54 REP 11 IND 0
ACTION TIMELINE
2 EVENTSAPR 9
Introduced in House
APR 9
Referred to the House Committee on Energy and Commerce.
BILL INFO
TypeHouse Bill
NumberHR 2767
Congress119th
StatusIn Committee
IntroducedApr 9, 2025
Last actionApr 9, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · ENERGY AND COMMERCE COMMITTEE · INTRODUCED APR 9, 2025
House BillHR 2767Health
BRAIN Act
INTRODUCED APR 9, 2025· LAST ACTION APR 9, 2025
PASSAGE CHANCES
—%
READING
13 min
COSPONSORS
65
COMPLEXITY
Moderate
